TaiMed Biologics Inc. (TPEX:4147)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
49.40
+1.35 (2.81%)
Apr 29, 2026, 1:30 PM CST

TaiMed Biologics Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
898.38580.23251.01274.11551.62
Upgrade
Short-Term Investments
869.641,072395.49309.93406.68
Upgrade
Trading Asset Securities
---58.75-
Upgrade
Cash & Short-Term Investments
1,7681,652646.5642.79958.3
Upgrade
Cash Growth
7.00%155.58%0.58%-32.92%-20.21%
Upgrade
Accounts Receivable
79.06103.02160.4998.24157.78
Upgrade
Other Receivables
48.4131.328.1625.4935.41
Upgrade
Receivables
127.48134.31188.65123.73193.19
Upgrade
Inventory
1,3991,5691,2711,3891,177
Upgrade
Prepaid Expenses
21.926.4110.014.153.54
Upgrade
Other Current Assets
6.2831.1635.635.082.59
Upgrade
Total Current Assets
3,3223,3942,1512,1652,335
Upgrade
Property, Plant & Equipment
807.39857.4908.26957.741,011
Upgrade
Long-Term Investments
15.72-0.943.44232.63
Upgrade
Other Intangible Assets
442.15539.4625.79724.38821.33
Upgrade
Other Long-Term Assets
223.18208.79207.58210.57211.19
Upgrade
Total Assets
4,8114,9993,8944,1014,611
Upgrade
Accounts Payable
810.7613.50.09122.58
Upgrade
Accrued Expenses
16.6611.637.4939.3951.64
Upgrade
Short-Term Debt
--200200-
Upgrade
Current Portion of Long-Term Debt
27.8427.2426.9714.32-
Upgrade
Current Portion of Leases
2.292.262.182.021.95
Upgrade
Current Unearned Revenue
106.2974.3291.1257.4824.34
Upgrade
Other Current Liabilities
19.4318.5619.9216.5724.57
Upgrade
Total Current Liabilities
253.51134.77361.17329.86225.08
Upgrade
Long-Term Debt
440.19468.03495.04521.68536
Upgrade
Long-Term Leases
22.8125.126.6728.1229.38
Upgrade
Long-Term Unearned Revenue
236.55347.53444.04505.6877.9
Upgrade
Other Long-Term Liabilities
-0.920.920.920.87
Upgrade
Total Liabilities
953.05976.341,3281,3861,669
Upgrade
Common Stock
2,7322,7312,5302,5262,523
Upgrade
Additional Paid-In Capital
2,4692,452986.67945.45925.14
Upgrade
Retained Earnings
-1,304-1,136-934.56-740.22-470.93
Upgrade
Comprehensive Income & Other
-38.88-23.89-16.13-15.83-35.97
Upgrade
Shareholders' Equity
3,8584,0232,5662,7152,942
Upgrade
Total Liabilities & Equity
4,8114,9993,8944,1014,611
Upgrade
Total Debt
493.12522.63750.86766.14567.32
Upgrade
Net Cash (Debt)
1,2751,130-104.35-123.35390.98
Upgrade
Net Cash Growth
12.86%----38.12%
Upgrade
Net Cash Per Share
4.674.21-0.41-0.491.55
Upgrade
Filing Date Shares Outstanding
273.2273.08253.01252.55252.33
Upgrade
Total Common Shares Outstanding
273.2273.08253.01252.55252.33
Upgrade
Working Capital
3,0693,2591,7901,8352,110
Upgrade
Book Value Per Share
14.1214.7310.1410.7511.66
Upgrade
Tangible Book Value
3,4163,4841,9401,9912,120
Upgrade
Tangible Book Value Per Share
12.5012.767.677.888.40
Upgrade
Land
194.61194.61194.61194.61194.61
Upgrade
Buildings
497.93495.41493.95493.54493.12
Upgrade
Machinery
458.82457.35455.56450.03446.9
Upgrade
Leasehold Improvements
4.644.644.644.644.64
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.